Good Adherence to HAART and Improved Survival in a Community HIV/AIDS Program
Author Information
Author(s): Abaasa Andrew M, Todd Jim, Ekoru Kenneth, Kalyango Joan N, Levin Jonathan, Odeke Emmanuel, Karamagi Charles AS
Primary Institution: The AIDS Support Organization (TASO)
Hypothesis
Does adherence to HAART improve survival rates in community HIV/AIDS treatment programs?
Conclusion
Good adherence to HAART is achievable and leads to improved survival in community HIV/AIDS programs like TASO in Uganda.
Supporting Evidence
- 78.2% of patients had a mean adherence to ART of > 95%.
- Non-adherence was associated with a mortality rate of 42.5 deaths per 100 patient-years.
- Patients with a CD4 count <50 cells/mm3 had a higher mortality risk.
Takeaway
Taking your HIV medicine regularly helps you live longer and healthier. This study shows that many people in Uganda are doing just that!
Methodology
The study was a retrospective cohort analysis of 897 patients who initiated HAART at TASO clinic, with adherence assessed through self-report and pill counts.
Potential Biases
Potential biases in adherence measurement due to reliance on self-reporting and unequal assessment between groups.
Limitations
The study design was retrospective, which may not control for all confounding factors affecting survival.
Participant Demographics
The majority of participants were female (75.3%), with a mean age of 38.6 years, and most had a CD4 count of 50 cells/mm3 or more.
Statistical Information
P-Value
0.11
Confidence Interval
95% CI: 2.22–5.56
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website